La Jolla, California
United States
44
2026-05-14
The entities that hold a legal rights for patent applications filed by inventor Timmer John C.:
John C. Timmer from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CD33 TARGETED IMMUNOTHERAPIES
#2 | 2026-02-26CLL-1 TARGETED IMMUNOTHERAPIES
#3 | 2025-11-27MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES
#4 | 2025-10-09DLL3 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#5 | 2025-07-10NON-IMMUNOGENIC SINGLE DOMAIN ANTIBODIES
#6 | 2025-03-20MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 BINDING DOMAIN AND A RECEPTOR BINDING REGION AND METHODS OF USING THE SAME
#7 | 2025-01-09SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#8 | 2024-03-28MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND METHODS OF USING THE SAME
#9 | 2023-11-02CD28 SINGLE DOMAIN ANTIBODIES AND MULTIVALENT AND MULTISPECIFIC CONSTRUCTS THEREOF
#10 | 2023-09-21MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES
#11 | 2023-04-20B7H3 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#12 | 2022-10-13SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#13 | 2022-10-13CD33 TARGETED IMMUNOTHERAPIES
#14 | 2022-10-13CLL-1 TARGETED IMMUNOTHERAPIES
#15 | 2022-10-06CD123 TARGETED IMMUNOTHERAPIES
#16 | 2022-05-26PD-1 single domain antibodies and therapeutic compositions thereof
#17 | 2021-12-09DLL3 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#18 | 2021-11-045T4 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#19 | 2021-01-28Serpin fusion polypeptides and methods of use thereof
#20 | 2021-01-07Serpin fusion polypeptides and methods of use thereof
#21 | 2020-06-25PDL1-binding proteins
#22 | 2020-06-18PD-1 single domain antibodies and therapeutic compositions thereof
#23 | 2020-05-07Non-Immunogenic Single Domain Antibodies
#24 | 2020-04-16Serpin fusion polypeptides and methods of use thereof
#25 | 2020-04-02SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#26 | 2020-02-20OX40-binding polypeptides and uses thereof
#27 | 2020-02-13Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same
#28 | 2019-11-14Type III secretion system targeting molecules
#29 | 2019-10-31MULTISPECIFIC POLYPEPTIDE CONSTRUCTS HAVING CONSTRAINED CD3 BINDING AND RELATED METHODS AND USES
#30 | 2019-10-10Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms
#31 | 2019-08-29Multivalent and multispecific OX40-binding fusion proteins
#32 | 2019-04-04Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids
#33 | 2019-01-10Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
#34 | 2018-06-28Serpin fusion polypeptides and methods of use thereof
#35 | 2017-11-09MULTIVALENT AND MULTISPECIFIC GITR-BINDING FUSION PROTEINS
#36 | 2017-07-13MULTIVALENT AND MULTISPECIFIC OX40-BINDING FUSION PROTEINS
#37 | 2017-07-13Multivalent and multispecific 41BB-binding fusion proteins
#38 | 2017-01-26Multispecific GITR-binding fusion proteins and methods of use thereof
#39 | 2017-01-19Multivalent and multispecific DR5-binding fusion proteins
#40 | 2016-11-03Type III secretion system targeting molecules
#41 | 2016-07-21Non-immunogenic single domain antibodies
#42 | 2015-05-28Serpin fusion polypeptides and methods of use thereof
#43 | 2015-05-28WAP domain fusion polypeptides and methods of use thereof
#44 | 2015-04-16Serpin fusion polypeptides and methods of use thereof
1129503 ⎘